Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
Clinical trial NCT03150056 · TERMINATED
Trial details
- NCT number
- NCT03150056
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-18
- Primary completion
- 2020-07-31
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.